Log in

Relevant bibliographies by topics / Insulin-like growth factor / Journal articles

Journal articles on the topic 'Insulin-like growth factor'

To see the other types of publications on this topic, follow the link: Insulin-like growth factor.

Author: Grafiati

Published: 4 June 2021

Last updated: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Insulin-like growth factor.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Purwana, Arie, Budiono Budiono, Jose RL Batubara, and Muhammad Faizi. "Association of Growth Velocity with Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Levels in Children with a Vegan Diet." Journal of Biomedicine and Translational Research 6, no. 1 (February 6, 2020): 6–10. http://dx.doi.org/10.14710/jbtr.v6i1.5474.

Full text

Abstract:

Background: The vegan diet in children provides the benefit of reducing the risk of being overweight and improving the fat profile. The risk that can occur in the provision of a vegan diet in children is anthropometric size below reference and low caloric intake. Growth hormone (GH) and Insulin like Growth Factors (IGFs) are powerful stimulators for longitudinal growth of bone and require insulin-like growth factor binding protein (IGFBPs) which acts as a transport protein for IGF-1. A vegan diet with lower calorie intake in children has lower IGF-I levels than children with an omnivorous diet.Objective: Examining the effect of vegan diets on IGF-1 levels, IGFBP-3 levels, and growth velocity.Methods: This study was done with a prospective cohort design. The study subjects were divided into two groups, namely the vegan group and the omnivorous group, then matched based on age and sex. During the study, anthropometric data collection, IGF-1 and IGFBP-3 levels measurements were done in both vegan children and omnivorous children.Results: During 6 months of observation, 22 subjects were divided into two groups, namely children with a vegan diet and children with an omnivorous diet. IGF-1 (ng / mL) in vegan children was 105.5 ± 47.3 compared to 102.7 ± 42.3 in omnivorous children with a value of p = 0.89. IGFBP-3 (ng / mL) in vegan children was 2146.4 ± 595.1 compared to 2142 ± 609.1 in omnivorous children with value of p = 0.99 and Growth Velocity (cm / 6 months) was 3.0 in vegan children (1.0-5.30), and 3.2 (2.6-6.5) in omnivorous children with value of p = 0.41.Conclusion:Children with vegan diet had IGF-1 level, IGFBP-3 level, and growth velocity that were the same as children with an omnivorous diet.

APA, Harvard, Vancouver, ISO, and other styles

2

Le Roith, Derek. "Insulin-Like Growth Factor." Hormone and Metabolic Research 31, no. 02/03 (January 1999): 41–42. http://dx.doi.org/10.1055/s-2007-978696.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Gu, Lijuan, Eun-Kyoung Mo, ZheMing Fang, BaiShen Sun, XueMei Zhu, and Chang-Keun Sung. "Partial Purification and Quantification of Insulin-like Growth Factor-I from Red Deer Antler." Journal of Life Science 17, no. 10 (October 30, 2007): 1321–29. http://dx.doi.org/10.5352/jls.2007.17.10.1321.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Kostecká, Z., and J. Blahovec. "Animal insulin-like growth factor binding proteins and their biological functions." Veterinární Medicína 47, No. 2 - 3 (March 30, 2012): 75–84. http://dx.doi.org/10.17221/5807-vetmed.

Full text

Abstract:

Insulin-like growth factor (IGF-I, IGF-II) action is influenced by until today known eight forms of insulin-like growth factor binding proteins (IGFBPs). They have been obtained not only from some human and animal tissues and body fluids but also from conditioned medium of cell cultures. An important biological property of the IGFBPs is their ability to increase the circulating half-life of the IGFs. They are able to act as potentiators of cell proliferation. As IGFBPs bind to cell surfaces, they may act either to deliver the IGFs to those surfaces for activation of specific receptors or to activate cell responses independently of receptor activation. Phosphorylation, glycosylation and proteolysis of IGFBPs influence their affinity to IGFs. The IGFBPs in the role of inhibitors may block the activity of the IGFs and be used for antimitogenic therapy. In the last time measuring of IGFBPs levels can be used for diagnosis determination of some endocrine diseases or in differential diagnostics.

APA, Harvard, Vancouver, ISO, and other styles

5

Donath, Marc Y., and J??rgen Zapf. "Insulin-Like Growth Factor I." Drugs & Aging 15, no. 4 (1999): 251–54. http://dx.doi.org/10.2165/00002512-199915040-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Arvat, Emanuela, Fabio Broglio, and Ezio Ghigo. "Insulin-Like Growth Factor I." Drugs & Aging 16, no. 1 (January 2000): 29–40. http://dx.doi.org/10.2165/00002512-200016010-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Bortvedt, Sarah F., and P. Kay Lund. "Insulin-like growth factor 1." Current Opinion in Gastroenterology 28, no. 2 (March 2012): 89–98. http://dx.doi.org/10.1097/mog.0b013e32835004c6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Nissley, Peter, and Wlodzimierz Lopaczynski. "Insulin-Like Growth Factor Receptors." Growth Factors 5, no. 1 (January 1991): 29–43. http://dx.doi.org/10.3109/08977199109000269.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Colbert, Lisa H., Clifford J. Rosen, Bret H. Goodpaster, Anne B. Newman, Stephen B. Kritchevsky, Suzanne Satterfield, Alka M. Kanaya, Dennis R. Taaffe, and Tamara B. Harris. "Insulin-Like Growth Factor-1." Journal of the American Geriatrics Society 52, no. 11 (November 2004): 1962–63. http://dx.doi.org/10.1111/j.1532-5415.2004.52529_1.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Verhage, A. R., and E. F. H. van Bommel. "Insulin-like growth factor-l." European Journal of Gastroenterology & Hepatology 10, no. 12 (December 1998): A68. http://dx.doi.org/10.1097/00042737-199812000-00220.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

NEELY, E. K., M. W. BEUKERS, Y. OH, P. COHEN, and R. G. ROSENFELD. "Insulin-Like Growth Factor Receptors." Acta Paediatrica 80, s372 (January 1991): 116–23. http://dx.doi.org/10.1111/j.1651-2227.1991.tb17985.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

NISSLEY, S. P., J. F. HASKELL, N. SASAKI, M. A. De VROEDE, and M. M. RECHLER. "Insulin-Like Growth Factor Receptors." Journal of Cell Science 1985, Supplement 3 (February 1, 1985): 39–51. http://dx.doi.org/10.1242/jcs.1985.supplement_3.5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Holly, Jeff M. P., and Claire M. Perks. "Insulin-Like Growth Factor Physiology." Endocrinology and Metabolism Clinics of North America 41, no. 2 (June 2012): 249–63. http://dx.doi.org/10.1016/j.ecl.2012.04.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Haluska, Paul. "Insulin-Like Growth Factor Pathway." Journal of Thoracic Oncology 5, no. 12 (December 2010): S478—S479. http://dx.doi.org/10.1097/01.jto.0000391374.71505.a2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Blumenschein, George. "Insulin-Like Growth Factor Receptor." Journal of Thoracic Oncology 6, no. 11 (November 2011): S1799—S1800. http://dx.doi.org/10.1097/01.jto.0000407563.14653.0c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Cara, José F. "Insulin-Like Growth Factors, Insulin-Like Growth Factor Binding Proteins and Ovarian Androgen Production." Hormone Research 42, no. 1-2 (1994): 49–54. http://dx.doi.org/10.1159/000184145.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Rosen, Clifford J. "Serum Insulin-like Growth Factors and Insulin-like Growth Factor-binding Proteins: Clinical Implications." Clinical Chemistry 45, no. 8 (August 1, 1999): 1384–90. http://dx.doi.org/10.1093/clinchem/45.8.1384.

Full text

Abstract:

Abstract The last decade has been characterized by a major investigative thrust into the physiology of two unique but ubiquitous peptides, insulin-like growth factor (IGF)-I and IGF-II. The regulatory systems that control the tissue bioactivity of the IGFs have been delineated, and subcellular signaling mechanisms have been clarified. Clearly, both tissue and circulating growth factor concentrations are important in defining the relationship between IGF-I and cell activity. Bone, liver, and circulatory IGF-I have received the most attention by investigators, in part because of the ease of measurement and the interaction with disease states such as osteoporosis. More recently, attention has focused on the role IGF-I plays in neoplastic transformation and growth. Two large prospective observational studies have demonstrated greater risk for prostate and breast cancer associated with high circulating concentrations of IGF-I. Animal models and in vitro studies confirm that there is a close, albeit complex, interaction between IGF-I signaling and bone turnover. This report will focus on: (a) IGF physiology, including IGF ligands, binding proteins, and proteases; (b) the relationship between IGF-I and bone mass in respect to risk for osteoporosis; (c) the heritable regulation of the IGF-I phenotype; and (d) the association between serum IGF-I and cancer risk. The IGFs remain a major area for basic and clinical investigations; future studies may define both diagnostic and therapeutic roles for these peptides or their related proteins in several disease states.

APA, Harvard, Vancouver, ISO, and other styles

18

Kobayashi, S., D. R. Clemmons, and M. A. Venkatachalam. "Colocalization of insulin-like growth factor-binding protein with insulin-like growth factor I." American Journal of Physiology-Renal Physiology 261, no. 1 (July 1, 1991): F22—F28. http://dx.doi.org/10.1152/ajprenal.1991.261.1.f22.

Full text

Abstract:

We report the localization of insulin-like growth factor I (IGF-I) and a 25-kDa form of insulin-like growth factor-binding protein (IGF-BP-1) in adult rat kidney. The antigens were localized using a rabbit anti-human IGF-I antibody, and a rabbit anti-human IGF-BP-1 antibody raised against human 25-kDa IGF-BP-1 purified from amniotic fluid. Immunohistochemistry by the avidin-biotin peroxidase conjugate technique showed that both peptides are located in the same nephron segments, in the same cell types. The most intense staining was in papillary collecting ducts. There was moderate staining also in cortical collecting ducts and medullary thick ascending limbs of Henle's loop. In collecting ducts the antigens were shown to be present in principal cells but not in intercalated cells. In distal convoluted tubules, cortical thick ascending limbs, and in structures presumptively identified as thin limbs of Henle's loops there was only modest staining. The macula densa, however, lacked immunoreactivity. Colocalization of IGF-I and IGF-BP-1 in the same cells supports the notion, derived from studies on cultured cells, that the actions of IGF-I may be modified by IGF-BPs that are present in the same location.

APA, Harvard, Vancouver, ISO, and other styles

19

TALLY, M., and K. HALL. "Insulin-Like Growth Factor II Effects Mediated through Insulin-Like Growth Factor II Receptors." Acta Paediatrica 79, s367 (April 1990): 67–73. http://dx.doi.org/10.1111/j.1651-2227.1990.tb11636.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Kim, Hye Jin, and Won Jun Lee. "Insulin-like Growth Factor-I Induces FATP1 Expression in C2C12 Myotubes." Journal of Life Science 24, no. 12 (December 30, 2014): 1284–90. http://dx.doi.org/10.5352/jls.2014.24.12.1284.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

ZAPF, J., E. SCHEIWILLER, H. P. GULER, and E. R. FROESCH. "Insulin and Insulin-Like Growth Factor I." Endocrinologia Japonica 34, Supplement (1987): 123–29. http://dx.doi.org/10.1507/endocrj1954.34.supplement_123.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Denko, C. W., and B. Boja. "Growth factors in asymptomatic osteoarthritis - insulin, insulin-like growth factor-1, growth hormone." Inflammopharmacology 2, no. 1 (March 1993): 71–76. http://dx.doi.org/10.1007/bf02663743.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

R. Abdulla, Parween, Bahez O. Ismael, and Kadhim F. Namiq. "INSULIN-LIKE GROWTH FACTOR-1 AND BREAST CANCER RISK IN KURDISH WOMEN." Journal of Sulaimani Medical College 8, no. 1 (April 15, 2018): 23–29. http://dx.doi.org/10.17656/jsmc.10147.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Lee, Chang Hoon, Chin Saeng Cho, Kyung-You Park, Joon Woo Kim, Gwan Won Lee, Byung Kwon Lee, and Jae Soo Lee. "The Role of Insulin-Like Growth Factor I and Binding Protein in Cholesteatoma Fibroblasts." Journal of Clinical Otolaryngology Head and Neck Surgery 14, no. 1 (May 2003): 113–17. http://dx.doi.org/10.35420/jcohns.2003.14.1.113.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Cohen, Pinchas. "Insulin-Like Growth Factor Binding Protein-3: Insulin-Like Growth Factor Independence Comes of Age." Endocrinology 147, no. 5 (May 1, 2006): 2109–11. http://dx.doi.org/10.1210/en.2006-0195.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Hasegawa, Yukihiro. "Relationship between Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3." Clinical Pediatric Endocrinology 5, Supple8 (1996): 89–93. http://dx.doi.org/10.1297/cpe.5.supple8_89.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Morimoto, L. M. "Variation in Plasma Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3: Genetic Factors." Cancer Epidemiology Biomarkers & Prevention 14, no. 6 (June 1, 2005): 1394–401. http://dx.doi.org/10.1158/1055-9965.epi-04-0694.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Gabbitas, Bari, and Ernesto Canalis. "Insulin-like growth factors sustain insulin-like growth factor-binding protein-5 expression in osteoblasts." American Journal of Physiology-Endocrinology and Metabolism 275, no. 2 (August 1, 1998): E222—E228. http://dx.doi.org/10.1152/ajpendo.1998.275.2.e222.

Full text

Abstract:

Insulin-like growth factors (IGFs) I and II are considered to be autocrine regulators of bone cell function. Recently, we demonstrated that IGF-I induces IGF-binding protein-5 (IGFBP-5) expression in cultures of osteoblast-enriched cells from 22-day fetal rat calvariae (Ob cells). In the present study, we postulated that IGFs play an autocrine role in the maintenance of IGFBP-5 basal expression in Ob cells. IGFBP-2 and -3, at concentrations that bind endogenous IGFs, decreased IGFBP-5 mRNA levels, as determined by Northern blot analysis, and protein levels, as determined by Western immunoblots of extracellular matrix extracts of Ob cells. IGFBP-2 and -3 in excess inhibited IGFBP-5 heterogeneous nuclear RNA levels, as determined by RT-PCR, and did not alter the half-life of IGFBP-5 mRNA in transcriptionally arrested Ob cells. In conclusion, blocking endogenous IGFs in Ob cells represses IGFBP-5 expression, suggesting that IGFs are autocrine inducers of IGFBP-5 synthesis in osteoblasts.

APA, Harvard, Vancouver, ISO, and other styles

29

King, Jeffery L., and Clyde Guidry. "Insulin-Like Growth Factor Binding Proteins Modulate Müller Cell Responses to Insulin-Like Growth Factors." Investigative Opthalmology & Visual Science 45, no. 8 (August 1, 2004): 2848. http://dx.doi.org/10.1167/iovs.04-0054.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Kim, Hye Jin, Ji Sun Hwang, Yi-Sub Kwak, and Won Jun Lee. "Insulin-like Growth Factor-I Induces Plectin and MACF1 Expression in C2C12 Myotubes." Journal of Life Science 22, no. 12 (December 30, 2012): 1651–57. http://dx.doi.org/10.5352/jls.2012.22.12.1651.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Chang, Shiuh Y., and Yat-Sen Ho. "Immunohistochemical analysis of insulin-like growth factor I, insulin-like growth factor I receptor and insulin-like growth factor II in endometriotic tissue and endometrium." Acta Obstetricia et Gynecologica Scandinavica 76, no. 2 (January 1997): 112–17. http://dx.doi.org/10.3109/00016349709050064.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Kim, Hye Jin, Hae Min Yoon, and Won Jun Lee. "Insulin-like Growth Factor-I Induces FABPpm Expression in C2C12 Myotubes." Journal of Life Science 25, no. 10 (October 30, 2015): 1098–102. http://dx.doi.org/10.5352/jls.2015.25.10.1098.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Thomas, A. G., J. M. Holly, F. Taylor, and V. Miller. "Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease." Gut 34, no. 7 (July 1, 1993): 944–47. http://dx.doi.org/10.1136/gut.34.7.944.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Lamas, Eugenia, Frédérique Zindy, Danielle Seurin, Christiane Guguen-Guillouzo, and Christian Brechot. "Expression of insulin-like growth factor II and receptors for insulin-like growth factor II, insulin-like growth factor I and insulin in isolated and cultured rat hepatocytes." Hepatology 13, no. 5 (May 1991): 936–40. http://dx.doi.org/10.1002/hep.1840130522.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Jain, S. "Insulin-Like Growth Factor-I Resistance." Endocrine Reviews 19, no. 5 (October 1, 1998): 625–46. http://dx.doi.org/10.1210/er.19.5.625.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Jain, Suparna, David W. Golde, Robert Bailey, and Mitchell E. Geffner. "Insulin-Like Growth Factor-I Resistance*." Endocrine Reviews 19, no. 5 (October 1, 1998): 625–46. http://dx.doi.org/10.1210/edrv.19.5.0348.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Camacho-Hübner, Cecilia, and Martin O. Savage. "Insulin-Like Growth Factor -I Deficiency." Hormone Research in Paediatrics 55, no. 1 (2001): 17–20. http://dx.doi.org/10.1159/000063457.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Yee, D. "Targeting insulin-like growth factor pathways." British Journal of Cancer 94, no. 4 (January 31, 2006): 465–68. http://dx.doi.org/10.1038/sj.bjc.6602963.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Choh Hao Li, Donald Yamashiro, R. Glenn Hammonds, and Manfred Westphal. "Synthetic insulin-like growth factor II." Biochemical and Biophysical Research Communications 127, no. 2 (March 1985): 420–24. http://dx.doi.org/10.1016/s0006-291x(85)80177-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Yakar, Shoshana, and Martin L. Adamo. "Insulin-Like Growth Factor 1 Physiology." Endocrinology and Metabolism Clinics of North America 41, no. 2 (June 2012): 231–47. http://dx.doi.org/10.1016/j.ecl.2012.04.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Roith, Derek Le. "The Insulin-Like Growth Factor System." Experimental Diabesity Research 4, no. 4 (2003): 205–12. http://dx.doi.org/10.1155/edr.2003.205.

Full text

Abstract:

The insulin-like growth factor (IGF) system in ubiquitous and plays a role in every tissue of the body. It is comprised of ligands, receptors and binding proteins, each with specific functions. While it plays an essential role in embryonic and post-natal development, the IGF system is also important in normal adult physiology. There are now numerous examples of diseases such as diabetes, cancer, and malnutrition in which the IGF system is a major player and, not surprisingly, there are attempts to affect these disorders by manipulating the system.

APA, Harvard, Vancouver, ISO, and other styles

42

Bayes-Genis, Antoni, Cheryl A. Conover, and Robert S. Schwartz. "The Insulin-Like Growth Factor Axis." Circulation Research 86, no. 2 (February 4, 2000): 125–30. http://dx.doi.org/10.1161/01.res.86.2.125.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Platz, Elizabeth A., Michael N. Pollak, Walter C. Willett, and Edward Giovannucci. "Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3." Journal of the American Academy of Dermatology 42, no. 6 (June 2000): 1003–7. http://dx.doi.org/10.1067/mjd.2000.103987.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Zimmermann, E. M., L. Li, Y. T. Hou, N. K. Mohapatra, and J. B. Pucilowska. "Insulin-like growth factor I and insulin-like growth factor binding protein 5 in Crohn's disease." American Journal of Physiology-Gastrointestinal and Liver Physiology 280, no. 5 (May 1, 2001): G1022—G1029. http://dx.doi.org/10.1152/ajpgi.2001.280.5.g1022.

Full text

Abstract:

Insulin-like growth factor (IGF)-I and its binding protein IGF binding protein 5 (IGFBP-5) were highly expressed in inflamed and fibrotic intestine in experimental Crohn's disease. IGF-I induced proliferation and increased collagen synthesis by smooth muscle cells and fibroblasts/myofibroblasts in vitro. Here we studied IGF-I and IGFBP-5 in Crohn's disease tissue. Tissue was collected from patients undergoing intestinal resection for Crohn's disease. IGF-I and IGFBP-5 mRNAs were quantitated by RNase protection assay and Northern blot analysis, respectively. In situ hybridization was performed to localize mRNA expression, and Western immunoblot was performed to quantitate protein expression. IGF-I and IGFBP-5 mRNAs were increased in inflamed/fibrotic intestine compared with normal-appearing intestine. IGF-I mRNA was expressed in multiple cell types in the lamina propria and fibroblast-like cells of the submucosa and muscularis externa. IGFBP-5 mRNA was highly expressed in smooth muscle of the muscularis mucosae and muscularis externa as well as fibroblast-like cells throughout the bowel wall. Tissue IGFBP-5 protein correlated with collagen type I ( r = 0.82). These findings are consistent with a mechanism whereby IGF-I acts on smooth muscle and fibroblasts/myofibroblasts to increase collagen synthesis and cellular proliferation; its effects may be modulated by locally expressed IGFBP-5.

APA, Harvard, Vancouver, ISO, and other styles

45

Duron, Emmanuelle, Benoît Funalot, Nadège Brunel, Joel Coste, Laurent Quinquis, Cécile Viollet, Joel Belmin, et al. "Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 in Alzheimer's Disease." Journal of Clinical Endocrinology & Metabolism 97, no. 12 (December 1, 2012): 4673–81. http://dx.doi.org/10.1210/jc.2012-2063.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Akmal, Sharifah Noor, Kankatsu Yun, Janet MacLay, Yoshikazu Higami, and Takayoshi Ikeda. "Insulin-like growth factor 2 and insulin-like growth factor binding protein 2 expression in hepatoblastoma." Human Pathology 26, no. 8 (August 1995): 846–51. http://dx.doi.org/10.1016/0046-8177(95)90005-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Feld, Stella M., and Raimund Hirschberg. "Insulin-like growth factor-I and insulin-like growth factor-binding proteins in the nephrotic syndrome." Pediatric Nephrology 10, no. 3 (May 1, 1996): 355–58. http://dx.doi.org/10.1007/s004670050124.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Feld, Stella M., and Raimund Hirschberg. "Insulin-like growth factor-I and insulin-like growth factor-binding proteins in the nephrotic syndrome." Pediatric Nephrology 10, no. 3 (June 1996): 355–58. http://dx.doi.org/10.1007/bf00866783.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

AC, Spichiger, K. Allenspach, Y. Zbinden, Doherr MG, S. Hiss, Blum JW, and SNSauter. "Plasma insulin-like growth factor-1 concentration in dogs with chronic enteropathies." Veterinární Medicína 51, No. 1 (March 19, 2012): 35–43. http://dx.doi.org/10.17221/5515-vetmed.

Full text

Abstract:

Plasma concentrations of insulin-like growth factor (IGF)-1 were examined in dogs suffering from food-responsive diarrhea (group FRD) or inflammatory bowel disease (group IBD) before and after treatment and compared with IGF-1 values in healthy dogs (group C). Blood of 76 dogs was sampled (FRDbefore treatment, n = 23; IBD before treatment, n = 11; C, n = 42) and after treatment (FRD, n = 15; IBD, n= 8) with a hypoallergenic diet combined with (group IBD) or without prednisolone (group FRD). A clinical score (Canine IBD Activity Index = CIBDAI) was applied to judge the health status in all dogs. Plasma concentration of IGF-1, of total protein, albumin, glucose, urea, non-esterified fatty acids (NEFA), and of the acute phase protein haptoglobin was measured in all dogs. The CIBDAI scores decreased during the treatment period in FRD and IBD (P < 0.05). IGF-1 concentrations were positively correlated with body weight (BW) (r<sub>sp</sub> = 0.65, P < 0.001) and values of IGF-1 were therefore normalized with BW. IGF-1/BW ratios were lower in FRD and IBD before treatment than in C (P < 0.01). <br />IGF-1/BW ratios increased in FRD (P < 0.05) dogs during treatment. Plasma glucose concentration was lower in FRD dogs before treatment than in C (P < 0.05), and NEFA concentrations were higher in FRDdogs before and after treatment than in C (P < 0.001). Haptoglobin concentrations were higher in IBD dogs before and after treatment than in all other groups (P < 0.05). In conclusion, chronic enteropathies reduce the plasma IGF-1 status in dogs. The increase of the IGF-1/BW ratio after treatment suggests that plasma IGF-1 concentration may help to judge the outcome of chronic enteropathies in dogs.

APA, Harvard, Vancouver, ISO, and other styles

50

Conover, C. A., J. T. Clarkson, and L. K. Bale. "Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action." Endocrinology 137, no. 6 (June 1996): 2286–92. http://dx.doi.org/10.1210/endo.137.6.8641177.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!